CEP19
Basic information
Region (hg38): 3:196706277-196712250
Previous symbols: [ "C3orf34" ]
Links
Phenotypes
GenCC
Source:
- obesity due to CEP19 deficiency (Strong), mode of inheritance: AR
- Bardet-Biedl syndrome (Supportive), mode of inheritance: AR
- obesity due to CEP19 deficiency (Supportive), mode of inheritance: AR
- obesity due to CEP19 deficiency (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Morbid obesity and spermatogenic failure | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Endocrine; Genitourinary | 24268657 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CEP19 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 19 | 22 | ||||
missense | 61 | 62 | ||||
nonsense | 4 | |||||
start loss | 1 | |||||
frameshift | 3 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 2 | 3 | |||
non coding | 5 | |||||
Total | 0 | 0 | 72 | 22 | 5 |
Variants in CEP19
This is a list of pathogenic ClinVar variants found in the CEP19 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-196707553-A-C | Uncertain significance (Nov 08, 2022) | |||
3-196707569-C-A | Uncertain significance (Dec 31, 2019) | |||
3-196707572-T-C | Benign/Likely benign (Jan 29, 2024) | |||
3-196707577-C-T | Uncertain significance (Aug 28, 2021) | |||
3-196707578-C-T | Uncertain significance (Sep 27, 2022) | |||
3-196707582-C-G | Uncertain significance (Jun 01, 2022) | |||
3-196707582-C-T | Uncertain significance (Mar 23, 2022) | |||
3-196707586-AGGACTGCAGTTGATC-A | Uncertain significance (Sep 01, 2021) | |||
3-196707602-G-A | Likely benign (Oct 30, 2023) | |||
3-196707616-C-T | Uncertain significance (Aug 19, 2021) | |||
3-196707618-A-C | Uncertain significance (Mar 10, 2022) | |||
3-196707624-A-G | Uncertain significance (Jan 28, 2022) | |||
3-196707629-A-G | Likely benign (Apr 18, 2023) | |||
3-196707630-T-C | Uncertain significance (Oct 13, 2022) | |||
3-196707643-G-A | Uncertain significance (Dec 01, 2021) | |||
3-196707649-CCTT-C | Uncertain significance (Aug 22, 2022) | |||
3-196707650-C-T | Likely benign (Jul 01, 2022) | |||
3-196707669-T-C | Uncertain significance (Aug 19, 2021) | |||
3-196707673-A-G | Uncertain significance (Nov 08, 2022) | |||
3-196707681-T-C | Uncertain significance (Nov 29, 2022) | |||
3-196707682-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
3-196707684-A-T | Uncertain significance (Jul 19, 2022) | |||
3-196707686-G-T | Likely benign (Nov 01, 2023) | |||
3-196707697-T-C | not specified | Uncertain significance (Aug 13, 2021) | ||
3-196707711-T-C | Uncertain significance (Oct 24, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CEP19 | protein_coding | protein_coding | ENST00000409690 | 2 | 6017 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0157 | 0.890 | 124774 | 0 | 18 | 124792 | 0.0000721 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.136 | 94 | 90.4 | 1.04 | 0.00000477 | 1116 |
Missense in Polyphen | 28 | 25.891 | 1.0815 | 359 | ||
Synonymous | 0.0882 | 30 | 30.6 | 0.980 | 0.00000151 | 287 |
Loss of Function | 1.40 | 4 | 8.39 | 0.477 | 6.03e-7 | 84 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000290 | 0.0000290 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000111 | 0.000111 |
Finnish | 0.000371 | 0.000371 |
European (Non-Finnish) | 0.0000536 | 0.0000530 |
Middle Eastern | 0.000111 | 0.000111 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Required for ciliation (PubMed:28625565, PubMed:28428259, PubMed:28659385). Recruits the RABL2B GTPase to the ciliary base to initiate ciliation. After specifically capturing the activated GTP-bound RABL2B, the CEP19-RABL2B complex binds intraflagellar transport (IFT) complex B from the large pool pre-docked at the base of the cilium and thus triggers its entry into the cilia (PubMed:28625565, PubMed:28428259). Involved in the early steps in cilia formation by recruiting the ciliary vesicles (CVs) to the distal end of the mother centriole where they fuse to initiate cilium assembly. Involved in microtubule (MT) anchoring to the centrosomes (PubMed:28659385). {ECO:0000269|PubMed:28428259, ECO:0000269|PubMed:28625565, ECO:0000269|PubMed:28659385}.;
- Disease
- DISEASE: Morbid obesity and spermatogenic failure (MOSPGF) [MIM:615703]: An autosomal recessive morbid obesity syndrome characterized by hypertension, fatty liver disease, insulin resistance, and decreased sperm counts. Variable clinical manifestations are early coronary artery disease with myocardial infarction before 45 years of age, type II diabetes mellitus, and intellectual disability. Morbid obese individuals are defined as having a BMI greater than 40. {ECO:0000269|PubMed:24268657}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0926
Intolerance Scores
- loftool
- rvis_EVS
- 0.01
- rvis_percentile_EVS
- 54.95
Haploinsufficiency Scores
- pHI
- 0.137
- hipred
- N
- hipred_score
- 0.292
- ghis
- 0.515
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cep19
- Phenotype
- homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- microtubule anchoring at centrosome;cilium assembly;vesicle targeting, trans-Golgi to periciliary membrane compartment
- Cellular component
- spindle pole;centrosome;centriole;cilium;ciliary basal body
- Molecular function
- protein binding